EGFR and non-small cell lung carcinoma: The expression of miR-21 showed a large heterogeneity, and we evaluated whether the different sensitivity to drug treatment may be related to variable cellular miR-21 expression profiles (Table S1) and to phospho-EGFR in a panel of NSCLC cells characterized by their EGFR status.